Dexcom, Inc. · NASDAQ:DXCM
Dexcom — Q2 2025 Earnings Presentation
11 slides from Dexcom's earnings presentation, Jul 30, 2025
Slide 1: Dexcom earnings Q2 2025
bpexcom Dexcom earnings Q2 2025
Slide 2: Safe harbor statement
Safe harbor statement This presentation contains “forward-looking statements" that are based on our management's beliefs and assumptions and on information available to management as of July 30, 2025. We intend for such forward-looking statements to be covered by the safe harbor provisions for forwa
Slide 3: Second quarter 2025
Second quarter 2025 iil O Strategic Highlights G7 15 day Key Financial $1.157 billion in revenue Highlights 15% organic revenue! growth over Q2'24 Generated 300+ bps of operating Received FDA clearance for Dexcom (15% US; 14% INT'L?) expense leverage compared to Q2'24 1. Growth was 15% on a reported
Slide 4: Second quarter performance
Second quarter performance Total Revenue & Organic Growth Rate”! Non-GAAP Gross Profit and Margin* (sm™) ($MM) $1200 ) $1,004 $994 Suna $1,036 SST $750, «$638 $626 $661 $596 $696 ioe se $600 $400 $300 $200 | [ae +3% +8% +14% +15% Ese 63.5% 63.0% 59.4% 57.5% 60.1% $0 $0 Q2'24 Q3'24 Q4'24 Ql25 Q2'25 Q
Slide 5: 2025 Guidance as of July 30, 2025
2025 Guidance as of July 30, 2025 2025 Annual Revenue and Profitability Guidance Non-GAAP Non-GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin*! USD Previous 4.600 billion ~62% ~21% ~30% USD Updated — 4. 600-4.625 ~62% ~21% ~30% billion 1 See appendix for the definition of
Slide 6: Appendix: Revenue Data and GAAP Reconciliations
bpexcom Appendix Revenue Data and GAAP Reconciliations
Slide 7: GAAP to non-GAAP reconciliation
Three Months Ended June 30, Three Months Ended June 30, (In millions) 2025 2024 (In millions, except per share data) 2025 2024 GAAP gross profit $ 688.8 $ 626.7 GAAP net income $ 179.8 $ 143.5 Amortization of intangible assets (1) 7.1 7.1 Amortization of intangible assets (1) 7.9 8.4 Business transi
Slide 8: Revenue Metrics By Component
Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 YTD' 23 YTD' 24 YTD' 25 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 651.9 $ 778.0 $ 873.8 $ 947.0 $ 854.3 $ 947.0 $ 951.8 $ 1,068.5 $ 997.2 $ 1,117.8 $ 1,429.9 $ 1,801.3 $ 2,115.0 Year over year growth 20% 30% 3
Slide 9: Revenue Metrics By Geography
Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 YTD' 23 YTD' 24 YTD' 25 Revenue Metrics By Geography US Revenue (millions) $ 526.0 $ 616.6 $ 713.6 $ 769.1 $ 653.2 $ 731.9 $ 701.9 $ 802.8 $ 750.5 $ 841.0 $ 1,142.6 $ 1,385.1 $ 1,591.5 Year over year growth (decline) 17% 21% 24% 27% 24% 19%
Slide 10: Organic Revenue
Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 YTD' 23 YTD' 24 YTD' 25 (1) Organic Revenue INT'L Revenue - Reported $ 215.5 $ 254.7 $ 261.4 $ 265.4 $ 267.8 $ 272.4 $ 292.3 $ 310.7 $ 285.5 $ 316.1 $ 470.2 $ 540.2 $ 601.6 Impact of Acquired Revenue 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Slide 11: Non-GAAP definitions
DexCom, Inc. Amortization of intangible assets - We are required under GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful lives. We exclude these non-cash amortization charges related to acquired intangible assets from our n